Honored to announce that Tomasz Rygiel, Chief Technology Officer and Co-founder of Cellis, has been invited to the 6th Macrophage-Directed Therapies Summit, taking place October 1-3, 2024, in Boston, MA. We are excited to connect with leading experts and exchange insights into the latest advancements in macrophage therapy. A big thank you to the organizers for this opportunity. We look forward to exploring new discoveries that drive innovation in this critical field! #MacrophageTherapy #CancerResearch #Innovation
